Despite NRAS, PTEN and AKT1 mutations have proven involvement in carcinogenesis [24–28], their frequency was described in a few reports only in primary NSCLC tumors [3, 4, 13, 14, 16]. The gene discussed is NRAS; the disease is non-small cell lung carcinoma.